South Korea
· Delayed Price · Currency is KRW Seegene Company Description
Seegene, Inc. manufactures and sells molecular diagnostics products worldwide.
It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products.
The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes.
The company has a collaboration with Werfen for the joint development of syndromic qPCR assays. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.
| Country | South Korea |
| Founded | 2000 |
| Industry | In Vitro and In Vivo Diagnostic Substances |
| Employees | 63 |
| CEO | Jong-Yoon Chun |
Contact Details
Address: Taewon Building Seoul, 05548 South Korea | |
| Phone | 82 2 2240 4000 |
| Website | seegene.com |
Stock Details
| Ticker Symbol | 096530 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Jong-Yoon Chun | Chief Executive Officer |